SCHEMBL1933126

SCHEMBL1933126

COC=Cc1cc(Cl)ccc1-c1ccc(Br)c2ccccc12

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
CRHR1 P34998 1/20 0.32
S100A4 P26447 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ABL1 P00519 1/20 0.31
ABCB1 P08183 1/20 0.31
BCR P11274 1/20 0.31
AURKA O14965 1/20 0.30
AURKB Q96GD4 1/20 0.30
MAT2A P31153 1/20 0.30
MDM2 Q00987 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12522809 1.00 ALDH1A1 (0.33) ALDH1A1CRHR1S100A4KDM4EMEN1
SCHEMBL8512290 0.84 CYP1A2 (0.34) ALDH1A1LMNAPOLB
SCHEMBL8512288 0.84 CYP1A2 (0.34) ALDH1A1LMNAPOLB
SCHEMBL17754462 0.82 PARP1 (0.36) ALDH1A1CRHR1S100A4KDM4EMEN1
SCHEMBL21356233 0.80 ABL1 (0.37) ALDH1A1KDM4EMEN1LMNAPOLB
SCHEMBL21356232 0.80 ABL1 (0.37) ALDH1A1KDM4EMEN1LMNAPOLB
SCHEMBL1933184 0.78 ERN1 (0.43) ALDH1A1S100A4KDM4EMEN1LMNA
SCHEMBL24275005 0.76 AHR (0.43) ALDH1A1KDM4EMEN1LMNAPOLB
SCHEMBL16168770 0.76 PKM (0.30)
SCHEMBL16282203 0.75 CRHR1 (0.44) ALDH1A1CRHR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9178161-B2 Benzo[c]phenanthrene compound and organic light-emitting device containing same CANON KABUSHIKI KAISHA (JP) 2015-11-03 US disclosed
US-9178161-B2 Benzo[c]phenanthrene compound and organic light-emitting device containing same CANON KABUSHIKI KAISHA (JP) 2015-11-03 US disclosed
US-20120235888-A1 NEW BENZO[c]PHENANTHRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2012-09-20 US disclosed
US-20120235888-A1 NEW BENZO[c]PHENANTHRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2012-09-20 US disclosed
WO-2011068034-A1 NEW BENZO[c]PHENANTHRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2011-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120235888-A1 NEW BENZO[c]PHENANTHRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME AHR, ARNT, NR0B1 ALDH1A1 244/4885CRHR1 1173/4885S100A4 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.